The inhibitory effect of laminin 1 and synthetic peptides deduced from the sequence in the laminin α1 chain on Aβ40 fibril formation in vitro

Neuroscience Letters

Volumn 251, Issue 1, 1998, Pages 65-68

  Monji, Akira ^a   Tashiro, Ken Ichiro ^b   Hayashi, Yosihito ^b   Yoshida, Ichiro ^a   Tashiro, Nobutada ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Electron microscopy; Laminin; Synthetic peptides; Thioflavine T fluorescence

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; LAMININ; SYNTHETIC PEPTIDE; THIOFLAVINE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; IN VITRO STUDY; NERVE FIBER GROWTH; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; LAMININ; MICROSCOPY, ELECTRON; PC12 CELLS; PEPTIDE FRAGMENTS; RATS;

EID: 0032541019     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00499-6     Document Type: Article

References (19)

1. Aksenova M.V., Aksenov M.Y., Butterfield D.A., Carney J.M. α-1-Antichymotrypsin interaction with Aβ(1-40) inhibits fibril formation but does not affect the peptide toxicity. Neurosci. Lett. 211:1996;45-48.
2. Aksenov M.Y., Aksenova M.Y., Butterfield D.A., Hensley K., Vigo-Pelfrey C., Carney J.M. Glutamate synthetase-induced enhancement of β-amyloid peptide Aβ(1-40) neurotoxicity accompanied by abrogation of fibril formation and Aβ fragmentation. J. Neurochem. 66:1996;2050-2056.
3. Bronfman F.C., Garrido J., Alvarez A., Morgan C., Inestrosa N.C. Laminin inhibits amyloid-β-peptide fibrillation. Neurosci. Lett. 218:1996;201-203.
4. Bronfman F.C., Soto C., Tapia L., Tapia V., Inestrosa N.C. Extracellular matrix regulates the amount of the β-amyloid precursor protein and its amyloidogenic fragments. J. Cell. Physiol. 166:1996;360-369.
5. Ghanta J., Shen C.-L., Kiessling L.L., Murphy R.M. A strategy for designing inhibitors of β-amyloid toxicity. J. Biol. Chem. 271:1996;29525-29528.
6. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:1993;76-83.
7. Luckenbill-Edds L. Laminin and the mechanism of neuronal outgrowth. Brain Res. Rev. 23:1997;1-27.
8. Murtomaki S., Risteri J., Risteri L., Koivisto U.M., Johansson S., Liesi P. Laminin and its neurite outgrowth-promoting domain in the brain of Alzheimer's disease and Down's syndrome patients. J. Neurosci. Res. 32:1992;261-273.
9. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
10. Salomon A.R., Marcinowski K.J., Friedland R.P., Zagorski M.G. Nicotine inhibits amyloid formation by the β-peptide. Biochemistry. 35:1996;13568-13578.
11. Soto C., Castano E.M. The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis. Biochem. J. 314:1996;701-707.
12. Soto C., Golabek A., Wisniewski T., Castano E.M. Alzheimer's β-amyloid peptide is conformationally modified by apolipoprotein E in vitro. NeuroReport. 7:1996;721-725.
13. Soto C., Kindy M.S., Baumann M., Frangione B. Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem. Biophys. Res. Commun. 226:1996;672-680.
14. Tashiro K., Sephel G.C., Weeks B., Sasaki M., Martin G.R., Kleinman H.K., Yamada Y. A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J. Biol. Chem. 264:1989;16174-16182.
15. Tashiro K., Nagata I., Yamashita N., Okazaki K., Ogomori K., Tashiro N., Anai M. A synthetic peptide deduced from the sequence in the cross-region of laminin A chain mediates neurite outgrowth, cell attachment and heparin binding. Biochem. J. 302:1994;73-79.
16. Timpl R., Brown C.J. The laminins. Matrix Biol. 14:1994;275-281.
17. Tomiyama K., Asano S., Suwa Y., Morita T., Kataoka K., Mori H., Endo N. Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem. Biophys. Res. Commun. 204:1994;76-83.
18. Webster S., Bradt B., Rogers J., Cooper N. Aggregation-state dependent activation of the classical complement pathway by the amyloid β peptide. J. Neurochem. 69:1997;388-398.
19. Yanker B.A. Mechanism of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.